AACAP Statement on Psychiatric Medications and Children’s Mental Health
Washington, DC - The American Academy of Child and Adolescent Psychiatry (AACAP) recommends that all treatment decisions, including the use of selective serotonin reuptake inhibitors (SSRIs), be made collaboratively by medical providers, patients, and families to ensure safe, effective, and individualized care.
Psychiatric medications, including SSRIs, are safe and effective when prescribed and monitored by licensed medical professionals. Despite recent headlines to the contrary, decades of rigorous research and clinical experience show no evidence that SSRIs cause violence. For many children and adolescents, these medications can be lifesaving by reducing symptoms, restoring functioning, and supporting recovery.
When clinically appropriate, SSRIs are a valuable treatment option for depression, obsessive-compulsive disorder, and anxiety disorders. Prescribing decisions follow comprehensive evaluations by trained physicians working closely with families. Medication is always one part of a comprehensive treatment plan that includes psychotherapy, school-based supports, and family involvement.
AACAP remains committed to advancing evidence-based care that promotes healing, resilience, and well-being for all young people.
###
The American Academy of Child and Adolescent Psychiatry promotes the healthy development of children, adolescents, and families through advocacy, education, and research. Child and adolescent psychiatrists are the leading physician authority on children’s mental health. For more information, please visit www.aacap.org
Media Contact:
Rob Grant, Communications Director
202.966.7300
rgrant@aacap.org
www.aacap.org